Viekira Pak Safety Alert Prompts Express Scripts Review Of Exclusive Coverage
This article was originally published in The Pink Sheet Daily
Express Scripts has asked its pharmacy and therapeutics committee to review FDA's recent safety alert for AbbVie's hepatitis C drugs and will make a decision on any coverage changes after that.
You may also be interested in...
What's in – and what fell out of – the massive US stimulus package.
US House leadership's COVID-19 aid package focuses on cost sharing relief for patients to ensure access to treatments and vaccines for the virus. The Senate's legislative proposal tried to provide Medicare reimbursement incentives to providers to facilitate uptake, but some of those provisions were later dropped.
Provisions adapted from DISARM Act would carve out antimicrobials from hospital bundled payments and allow reimbursement equal to 100% of a drug’s average sales price.